# Arcadia Biosciences, Inc.: overview RKDA · Nasdaq · CIK 1469443 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/rkda.md) · [Financials](/companies/rkda/financials.md) · [Filings](/companies/rkda/filings.md) · [Insiders](/companies/rkda/insiders.md) Latest reported revenue: [$1.4m](/filings/0001193125-26-349205.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-349205). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,537](/filings/0001193125-25-272375.md) | [1,216 d](/filings/0001193125-26-126238.md) | [1,200](/filings/0001193125-26-223990.md) | [1,455](/filings/0001193125-26-349205.md) | [1,302](/filings/0001193125-25-272375.md) | [901 d](/filings/0001193125-26-126238.md) | [1,100](/filings/0001193125-26-223990.md) | [1,443](/filings/0001193125-26-349205.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(114.5%)](/filings/0001193125-25-272375.md) | [(187.4%) d](/filings/0001193125-26-126238.md) | [44.2%](/filings/0001193125-26-223990.md) | [(34.4%)](/filings/0001193125-26-349205.md) | [(88.5%)](/filings/0001193125-25-272375.md) | [(152.6%) d](/filings/0001193125-26-126238.md) | [(70.8%)](/filings/0001193125-26-223990.md) | [(34.4%)](/filings/0001193125-26-349205.md) | | Net margin | % | [(104.9%)](/filings/0001193125-25-272375.md) | [(334.2%) d](/filings/0001193125-26-126238.md) | [216.6%](/filings/0001193125-26-223990.md) | [(306.4%)](/filings/0001193125-26-349205.md) | [65.7%](/filings/0001193125-25-272375.md) | [(148.3%) d](/filings/0001193125-26-126238.md) | [(398.6%)](/filings/0001193125-26-223990.md) | [(434.2%)](/filings/0001193125-26-349205.md) | | Diluted EPS | $ per share | [(1.18)](/filings/0001193125-25-272375.md) | not reported | [1.90](/filings/0001193125-26-223990.md) | [(3.26)](/filings/0001193125-26-349205.md) | [0.62](/filings/0001193125-25-272375.md) | not reported | [(2.11)](/filings/0001193125-26-223990.md) | [(2.09)](/filings/0001193125-26-349205.md) | | Free cash flow | $k | [(1,752) d](/filings/0001193125-25-272375.md) | [(2,209) d](/filings/0001193125-26-126238.md) | [(1,588)](/filings/0001193125-26-223990.md) | [(2,033) d](/filings/0001193125-26-349205.md) | [(257) d](/filings/0001193125-25-272375.md) | [(822) d](/filings/0001193125-26-349205.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [6.8](/filings/0000950170-23-011019.md) | [7.4](/filings/0000950170-24-038176.md) | [4.5](/filings/0000950170-25-044487.md) | [5.0](/filings/0001193125-26-126238.md) | [4.9](/filings/0001193125-26-126238.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(524.0%)](/filings/0000950170-23-011019.md) | [(188.8%)](/filings/0000950170-24-038176.md) | [(137.0%)](/filings/0000950170-25-044487.md) | [(72.3%)](/filings/0001193125-26-126238.md) | [(51.5%)](/filings/0001193125-26-126238.md) | | Net margin | % | [(216.2%)](/filings/0000950170-23-011019.md) | [(207.3%)](/filings/0000950170-24-038176.md) | [(313.9%)](/filings/0000950170-25-044487.md) | [(139.5%)](/filings/0001193125-26-126238.md) | [(48.1%)](/filings/0001193125-26-126238.md) | | Diluted EPS | $ per share | [(27.56)](/filings/0000950170-23-011019.md) | [(25.65)](/filings/0000950170-23-011019.md) | [(11.29)](/filings/0000950170-25-044487.md) | [(5.17)](/filings/0001193125-26-126238.md) | [(1.71)](/filings/0001193125-26-126238.md) | | Free cash flow | $m | [(26.9)](/filings/0000950170-23-011019.md) | [(14.0)](/filings/0000950170-24-038176.md) | [(15.3)](/filings/0000950170-25-044487.md) | [(9.6)](/filings/0001193125-26-126238.md) | [(4.7)](/filings/0001193125-26-349205.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rkda/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $16.1k | 23,738 | | New +23,738 | | [StoneX Group Inc.](/funds/913760.md) | 2026-06-30 | $11.3k | 13,682 | | New +13,682 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $11.0k | 16,135 | | Reduced −15,608 | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $10.5k | 15,475 | | New +15,475 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.2k | 12,146 | | Unchanged | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $7.0k | 10,245 | | New +10,245 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.5k | 9,644 | | Unchanged | | [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $81 | 120 | | Unchanged | | [HRT FINANCIAL LP](/funds/1475597.md) | 2026-06-30 | $60 | 88,386 | | New +88,386 | | [TD Waterhouse Canada Inc.](/funds/1999606.md) | 2026-06-30 | $50 | 70 | | New +70 | ## Recent filings [All 596 filings](/companies/rkda/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-15 | 15:01 ET | [8-K](/filings/0001193125-26-391780.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-391780 | | 2026-09-04 | 16:05 ET | [8-K](/filings/0001193125-26-383642.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-383642 | | 2026-08-13 | 16:13 ET | [10-Q](/filings/0001193125-26-349205.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349205 | | 2026-08-13 | 16:10 ET | [8-K](/filings/0001193125-26-349180.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349180 | | 2026-08-10 | 16:17 ET | [DEF 14A](/filings/0001193125-26-342437.md) | Proxy statement, period 2026-08-10 | 0001193125-26-342437 | | 2026-08-10 | 18:49 ET | [8-K](/filings/0001193125-26-340664.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-340664 | | 2026-07-02 | 16:21 ET | [8-K](/filings/0001193125-26-294619.md) | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-294619 | | 2026-06-15 | 11:31 ET | [8-K](/filings/0001193125-26-270560.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-270560 | | 2026-05-14 | 16:07 ET | [10-Q](/filings/0001193125-26-223990.md) | Quarterly report, period 2026-03-31 | 0001193125-26-223990 | | 2026-05-14 | 16:06 ET | [8-K](/filings/0001193125-26-223985.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-223985 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-126238.md), filed Mar 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/41d25745-6aed-4b52-9bdd-a5717ad0f310) ## About the filer - CIK: 1469443 - Tickers: RKDA - Exchange: Nasdaq - SIC code: 1311 Crude Petroleum & Natural Gas - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.